CHI Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-333,945
| Closed | -$1.81M | – | 25 |
|
|
2022
Q4 | $1.81M | Buy |
333,945
+10,000
| +3% | +$54.3K | 0.48% | 19 |
|
|
2022
Q3 | $4.05M | Sell |
323,945
-443,290
| -58% | -$5.54M | 1.09% | 16 |
|
|
2022
Q2 | $3.79M | Buy |
767,235
+278,600
| +57% | +$1.38M | 1.45% | 16 |
|
|
2022
Q1 | $3.71M | Buy |
488,635
+258,635
| +112% | +$1.97M | 1.58% | 16 |
|
|
2021
Q4 | $2.35M | Buy |
230,000
+180,000
| +360% | +$1.84M | 0.78% | 17 |
|
|
2021
Q3 | $671K | Hold |
50,000
| – | – | 0.2% | 17 |
|
|
2021
Q2 | $1.1M | Hold |
50,000
| – | – | 0.26% | 16 |
|
|
2021
Q1 | $1.2M | Sell |
50,000
-12,000
| -19% | -$289K | 0.24% | 15 |
|
|
2020
Q4 | $1.12M | Sell |
62,000
-22,000
| -26% | -$396K | 0.31% | 14 |
|
|
2020
Q3 | $970K | Buy |
84,000
+40,000
| +91% | +$462K | 0.35% | 14 |
|
|
2020
Q2 | $1.07M | Buy |
+44,000
| New | +$1.07M | 0.42% | 12 |
|